- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02337699
Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain (GASPA)
DORSAL ROOT GANGLION STIMULATION AS TREATMENT FOR POSTSURGICAL GROIN PAIN (GASPA Study)
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
-
Nieuwegein, Nederländerna
- St Antonius Ziekenhuis
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Main Study
Inclusion Criteria:
- Male
- Age between >18 and <65 years
- Unilateral post surgical groin pain for >6 months
- Pain localized to the region defined by the anterior superior iliac spine (ASIS), the pubic tubercle, and the groin-gluteal-greater trochanter triangles (3G) point,
- Pain has no surgical indication
- Subjects meet the criteria for SCS implantation as set out in the Dutch Neuromodulation Society Guideline
- Pain characterized by neuropathy and/or allodynia
- Average daily baseline pain intensity baseline VAS greater than or equal to 50 mm on a 100mm VAS scale
- Patient willing and able to give informed consent and to participate in observational study
Exclusion Criteria:
- Inability to speak/read Dutch
- Bilateral and/or recurrent hernia.
- Radiofrequency or injection therapy at or close to a target DRG in the 90 days prior to enrolment
- Current illicit drug use and/or alcohol dependence
- Active infection, or conditions or indwelling devices that pose an increased risk of infection
- Active implantable device including implantable cardiac defibrillator, pacemaker, spinal cord stimulator or intrathecal drug pump
- Participation in another clinical study during the study period.
- Any other disorder, condition, or circumstance that, in the opinion of the principal investigator, represents a risk to successful completion of all study activities.
Additional Criteria for nested feasibility study
Additional Inclusion Criteria
- Participation in the observational study
- Sign off for sub-study on patient informed consent
Additional Exclusion Criteria
1. For sub-study participation only: pain conditions [aside from the post surgical groin pain to be treated], extensive scar tissue, skin conditions, or sensorimotor abnormalities in the areas for QST assessments: the painful groin, the contralateral groin, the ipsilateral arm, and the contralateral hand
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Treated Subjects
All subjects recruited into the main study treated with the Axium neurostimulator
|
|
|
QST Group
A sub-set of the main study group who also consent to take part in the Quantitative Sensory Testing based feasibility study
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Main Study: Pain Relief - Assessed be Change in Pain Intensity from Pre-Treatment Baseline
Tidsram: Post implantation at; 1, 3 and 6 months
|
Post implantation at; 1, 3 and 6 months
|
|
Feasibility Study: To determine subject acceptance of the described QST methodology and protocol; assessed using a 5 point Likert scale
Tidsram: Baseline then Post implantation at; 1, 3 and 6 months
|
Baseline then Post implantation at; 1, 3 and 6 months
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 25-SMI-2014
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .